UM

Browse/Search Results:  1-3 of 3 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Enhancement of the bioavailability of a novel anticancer compound (acetyltanshinone IIA) by encapsulation within mPEG-PLGA nanoparticles: A study of formulation optimization, toxicity, and pharmacokinetics Journal article
Oncotarget, 2017,Volume: 8,Issue: 7,Page: 12013-12030
Authors:  Wang Q.;  Wei N.;  Liu X.;  Chang A.;  Luo K.Q.
Favorite  |  View/Download:5/0  |  Submit date:2018/12/18
Acetyltanshinone Iia  Anticancer Drugs  Bioavailability  Mpeg-plga  Pharmacokinetics  Toxicity  
A mechanism for 1,4-Benzoquinone-induced genotoxicity Journal article
Oncotarget, 2016,Volume: 7,Issue: 29,Page: 46433-46447
Authors:  Son M.Y.;  Deng C.-X.;  Hoeijmarkers J.H.;  Rebel V.I.;  Hasty P.
Favorite  |  View/Download:7/0  |  Submit date:2018/12/13
Double Strand Break Repair  Fanconi Anemia  Replication Fork Maintenance  Type 1 Topoisomerase  
Synergistic anticancer effects of triptolide and celastrol, two main compounds from thunder god vine Journal article
Oncotarget, 2015,Volume: 6,Issue: 32,Page: 32790
Authors:  Jiang Q.-W.;  Cheng K.-J.;  Mei X.-L.;  Qiu J.-G.;  Zhang W.-J.;  Xue Y.-Q.;  Qin W.-M.;  Yang Y.;  Zheng D.-W.;  Chen Y.;  Wei M.-N.;  Zhang X.;  Lv M.;  Chen M.-W.;  Wei X.;  Shi Z.
Favorite  |  View/Download:10/0  |  Submit date:2018/10/30
Cancer  Celastrol  Combination Therapy  Triptolide